Torray Investment Partners LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 98758 Bethesda, MD

Position in VRTX

as of Mar 31, 2026 · filed May 1, 2026 Compact

Position Value

$6,870,464

-$141,201 QoQ

Shares Held

15,386

-0.5% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

1.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 88.73651371376576.ToString("F0")% Shared 0.ToString("F0")% None 11.26348628623424.ToString("F0")%

Healthcare · as of Mar 31, 2026

Torray Investment Partners LLC holds $54,354,232 across 8 Biotechnology names. VRTX ranks #2 (12.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	645,425	$30,961,037
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	15,386	$6,870,464
3	BMRN	Biomarin Pharmaceutical Inc	78,170	$4,415,823
4	KRYS	Krystal Biotech, Inc.	12,032	$3,108,106
5	AXSM	Axsome Therapeutics, Inc.	14,774	$2,497,101
6	HALO	Halozyme Therapeutics, Inc.	38,179	$2,467,508
7	SNDX	Syndax Pharmaceuticals Inc	104,868	$2,449,716
8	VSTM	Verastem, Inc.	298,958	$1,584,477

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,870,464	15,386	-0.5%	Shares	Sole	2026-05-01
2025-12-31	$7,011,665	15,466	-4.9%	Shares	Sole	2026-01-28
2025-09-30	$6,366,108	16,255	-3.7%	Shares	Sole	2025-10-22
2025-06-30	$7,514,530	16,879	+7.4%	Shares	Sole	2025-08-05
2025-03-31	$7,621,855	15,721	-1.8%	Shares	Sole	2025-05-08
2024-12-31	$6,446,421	16,008	+1.6%	Shares	Sole	2025-02-06
2024-09-30	$7,325,475	15,751	+13.0%	Shares	Sole	2024-11-05
2024-06-30	$6,533,019	13,938	+0.3%	Shares	Sole	2024-08-06
2024-03-31	$5,809,920	13,899	-1.2%	Shares	Sole	2024-05-10
2023-12-31	$5,724,128	14,068	—	Shares	Sole	2024-02-08
No filing history on record for this holder in this stock.